Kurrikoff K - Search Results

1

Editorial on Special Issue "Precision Delivery of Drugs and Imaging Agents with Peptides".

Kurrikoff K, Teesalu T. Kurrikoff K, et al. Pharmaceutics. 2022 Feb 23;14(3):486. doi: 10.3390/pharmaceutics14030486. Pharmaceutics. 2022. PMID: 35335863 Free PMC article.

2

PepFect14 peptide vector for efficient gene delivery in cell cultures.

Veiman KL, Mäger I, Ezzat K, Margus H, Lehto T, Langel K, Kurrikoff K, Arukuusk P, Suhorutšenko J, Padari K, Pooga M, Lehto T, Langel Ü. Veiman KL, et al. Among authors: kurrikoff k. Mol Pharm. 2013 Jan 7;10(1):199-210. doi: 10.1021/mp3003557. Epub 2012 Dec 14. Mol Pharm. 2013. PMID: 23186360

3

Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosis and Cancer In Vitro Models.

Kiisholts K, Kurrikoff K, Arukuusk P, Porosk L, Peters M, Salumets A, Langel Ü. Kiisholts K, et al. Among authors: kurrikoff k. Pharmaceutics. 2021 Oct 5;13(10):1618. doi: 10.3390/pharmaceutics13101618. Pharmaceutics. 2021. PMID: 34683911 Free PMC article.

4

Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293.

Porosk L, Nebogatova J, Härk HH, Vunk B, Arukuusk P, Toots U, Ustav M, Langel Ü, Kurrikoff K. Porosk L, et al. Among authors: kurrikoff k. Pharmaceutics. 2022 Sep 14;14(9):1949. doi: 10.3390/pharmaceutics14091949. Pharmaceutics. 2022. PMID: 36145697 Free PMC article.

5

The Development of Cell-Penetrating Peptides for Efficient and Selective In Vivo Expression of mRNA in Spleen Tissue.

Porosk L, Härk HH, Arukuusk P, Haljasorg U, Peterson P, Kurrikoff K. Porosk L, et al. Among authors: kurrikoff k. Pharmaceutics. 2023 Mar 15;15(3):952. doi: 10.3390/pharmaceutics15030952. Pharmaceutics. 2023. PMID: 36986813 Free PMC article.

6

Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications.

Härk HH, Porosk L, de Mello LR, Arukuusk P, da Silva ER, Kurrikoff K. Härk HH, et al. Among authors: kurrikoff k. Pharmaceutics. 2023 Mar 9;15(3):883. doi: 10.3390/pharmaceutics15030883. Pharmaceutics. 2023. PMID: 36986744 Free PMC article.

7

Cell-penetrating peptides for the delivery of nucleic acids.

Lehto T, Kurrikoff K, Langel Ü. Lehto T, et al. Among authors: kurrikoff k. Expert Opin Drug Deliv. 2012 Jul;9(7):823-36. doi: 10.1517/17425247.2012.689285. Epub 2012 May 17. Expert Opin Drug Deliv. 2012. PMID: 22594635 Review.

8

The future of peptides in cancer treatment.

Kurrikoff K, Aphkhazava D, Langel Ü. Kurrikoff K, et al. Curr Opin Pharmacol. 2019 Aug;47:27-32. doi: 10.1016/j.coph.2019.01.008. Epub 2019 Mar 8. Curr Opin Pharmacol. 2019. PMID: 30856511 Review.

9

Tumor gene therapy by systemic delivery of plasmid DNA with cell-penetrating peptides.

Künnapuu K, Veiman KL, Porosk L, Rammul E, Kiisholts K, Langel Ü, Kurrikoff K. Künnapuu K, et al. Among authors: kurrikoff k. FASEB Bioadv. 2018 Nov 26;1(2):105-114. doi: 10.1096/fba.1026. eCollection 2019 Feb. FASEB Bioadv. 2018. PMID: 32123824 Free PMC article.

10

Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics.

Kurrikoff K, Vunk B, Langel Ü. Kurrikoff K, et al. Expert Opin Biol Ther. 2021 Mar;21(3):361-370. doi: 10.1080/14712598.2021.1823368. Epub 2020 Sep 23. Expert Opin Biol Ther. 2021. PMID: 32938243 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page